INSIGHTS ON UPSTREAM MANUFACTURING
-
Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development
The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.
-
Efficient Clone Screening With Increased Process Control And Integrated Cell Health And Titer Measurements With The Cydem VT Automated Clone Screening System
Automated screening of antibody-producing clones provides real-time cell health and titer data, helping developers identify top-performing candidates earlier and with confidence.
-
How mAbs Have Transformed Breast Cancer Treatment, And Where Is It Going Next
Monoclonal antibody therapies are reshaping breast cancer treatment. Explore the latest manufacturing advances and research solutions helping developers accelerate therapy production at every stage.
-
Patient-Derived Organoids For Cell Therapy Development
Patient-derived organoids offer a more accurate way to test cell therapies by preserving the complex tumor environments that determine whether these treatments will actually work.
-
Moving Beyond Animal Models With iPSC-Based Models8/12/2026
Animal models are giving way to iPSC-based systems that better reflect human biology, offering researchers a more accurate and ethical path to drug discovery.
-
From 2D To Organ-On-A-Chip: Platforms Powering Modern Disease Models8/12/2026
Disease modeling has evolved well beyond animal studies, and understanding which platform fits which research question is now a critical skill for modern biology teams.
-
From DNA To IND In 6 Months: Accelerated Development Backed By Experience8/10/2026
A rapid, integrated biologics development strategy can achieve IND readiness in as little as six months by combining parallel workflows, early risk mitigation, advanced technologies, robust analytics, and regulatory planning.
-
Improving Bioprocessing Outcomes With The CHOZN® Elite Host Cell Line8/7/2026
Accelerate cell line development with a host engineered for high expression, streamlined clone selection, flexible gene integration, and scalable industrial performance.
UPSTREAM MANUFACTURING SOLUTIONS
-
Advance cell line development with a stable, high-producing CHO host supporting predictable growth, efficient clone selection, and scalable fed-batch and perfusion processes.
-
The GS Gene Expression System® with GS Ori-Go vectors delivers lead clone titers above 11 g/L, eliminates MSX selection, and cuts timelines by up to 2 weeks — backed by 100+ approved commercial products.
-
cGMP liquid solutions streamline upstream and downstream bioprocessing. Reclaim cleanroom capacity, enhance process consistency, and reduce contamination risks from development to commercial production.
-
Automated buffer and media preparation is reshaping bioprocessing operations, offering over 50% time savings, reduced labor demands, and safer floor-level handling compared to traditional methods.
-
Learn about an automated hydration system that replaces manual powder prep with a closed-loop, single-use skid designed to cut turnaround times and reduce contamination risk in bioprocessing.